Lv4
500 积分 2022-05-30 加入
健康受试者I期临床试验不良事件分级标准专家共识
13天前
已完结
Multifaceted Nature of DNA Polymerase θ
1个月前
已完结
PARP in colorectal cancer: Molecular mechanisms, immunity, clinical trials, and drug combinations
4个月前
已关闭
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
5个月前
已完结
Treatment With Niraparib Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian Cancer
5个月前
已完结
Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial
5个月前
已完结
Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial
5个月前
已完结
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
5个月前
已完结
453 Senaparib maintenance in newly diagnosed advanced ovarian cancer: FLAMES study
5个月前
已关闭
Effect of a strong CYP3A4 inhibitor and inducer on the pharmacokinetics of senaparib (IMP4297) in healthy volunteers: A drug–drug interaction study
5个月前
已完结
皖公网安备34019202002308
